Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches C Ram, AK Jha, A Ghosh, S Gairola, AM Syed, US Murty, VGM Naidu, ... European journal of pharmacology 885, 173503, 2020 | 54 | 2020 |
Toll-like receptor 4: An attractive therapeutic target for acute kidney injury AK Jha, S Gairola, S Kundu, P Doye, AM Syed, C Ram, US Murty, ... Life Sciences 271, 119155, 2021 | 36 | 2021 |
Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction S Gairola, C Ram, AM Syed, P Doye, U Kulhari, MN Mugale, US Murty, ... European Journal of Pharmacology 910, 174479, 2021 | 20 | 2021 |
Biochanin A alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis and inflammation by inhibiting the TGF-β1/Smad2/3 and NF-kB/NLRP3 signaling axis in mice C Ram, S Gairola, AM Syed, U Kulhari, S Kundu, MN Mugale, US Murty, ... Life Sciences 298, 120527, 2022 | 17 | 2022 |
Biochanin A Ameliorates Nephropathy in High-Fat Diet/Streptozotocin-Induced Diabetic Rats: Effects on NF-kB/NLRP3 Axis, Pyroptosis, and Fibrosis C Ram, S Gairola, S Verma, MN Mugale, SR Bonam, US Murty, BD Sahu Antioxidants 12 (5), 1052, 2023 | 15 | 2023 |
Biological activities, pharmacokinetics and toxicity of nootkatone: A Review AK Jha, S Gairola, S Kundu, P Doye, AM Syed, C Ram, U Kulhari, ... Mini Reviews in Medicinal Chemistry 22 (17), 2244-2259, 2022 | 7 | 2022 |
Carvacrol preserves antioxidant status and attenuates kidney fibrosis via modulation of TGF-β1/Smad signaling and inflammation C Ram, S Gairola, AM Syed, S Verma, MN Mugale, BD Sahu Food & Function 13 (20), 10587-10600, 2022 | 7 | 2022 |
Chronic kidney disease activates the HDAC6-inflammatory axis in the heart and contributes to myocardial remodeling in mice: inhibition of HDAC6 alleviates chronic kidney … S Kundu, S Gairola, S Verma, MN Mugale, BD Sahu Basic Research in Cardiology, 1-22, 2024 | | 2024 |
Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues S Gairola, A Sinha, RK Kaundal Inflammopharmacology 32 (1), 287-305, 2024 | | 2024 |
Infectious diseases and its global epidemiology B Baral, K Mamale, S Gairola, C Chauhan, A Dey, RK Kaundal Nanostructured Drug Delivery Systems in Infectious Disease Treatment, 1-24, 2024 | | 2024 |